Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Laryngol Otol ; 127(4): 359-63, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23406694

RESUMO

OBJECTIVE: To determine whether the administration of mitomycin C prevents propylene glycol exposure from inducing middle-ear cholesteatoma and otitis media, in a rat model. METHODS: Twenty-four Wistar rats underwent intratympanic injections on days 1, 8 and 15, via the tympanic membrane pars tensa, in both the right and left ears. The right ear injection solution contained 50 per cent propylene glycol, gentamicin and saline (0.9 per cent), while the left ear solution contained 50 per cent propylene glycol, gentamicin and mitomycin C. Animals were sacrificed and examined. RESULTS: There were statistically significant differences between the control and experimental groups for tympanic bulla mucosal thickness (p = 0.004) but not for tympanic membrane thickness (p = 0.371), otomicroscopic findings (p = 0.262), or the presence of exudate (p = 0.125), fibrosis (p = 1.000) or cholesteatoma (p = 0.687). CONCLUSION: Intratympanic mitomycin C was ineffective in preventing middle-ear cholesteatoma and otitis media in this rat model.


Assuntos
Colesteatoma da Orelha Média/prevenção & controle , Mitomicina/farmacologia , Otite Média/prevenção & controle , Membrana Timpânica/efeitos dos fármacos , Animais , Masculino , Análise por Pareamento , Propilenoglicol/farmacologia , Ratos , Ratos Wistar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...